Sí en los referendos sobre la marihuana: Alaska, Oregón y el Distrito de Columbia legalizarán la hierba

Noticias

Sí en los referendos sobre la marihuana: Alaska, Oregón y el Distrito de Columbia legalizarán la hierba

20 octubre 2014

California legalizó la marihuana medicinal en 1996 y, el próximo mes de noviembre, Alaska, Oregón y el Distrito de Columbia decidirán si siguen las políticas de drogas del estado de Washington y Colorado para legalizar la marihuana recreativa. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

The decision by California voters in 1996 to legalize medical marijuana produced a wave of similar initiatives around the country. Less than two decades later, over half the states allow at least limited medical use. Now it looks as though recreational use of the drug may follow the same path.

In 2012, Washington State and Colorado legalized recreational marijuana. This November, voters in Alaska, Oregon and the District of Columbia will decide whether to do the same — effectively disregarding the misguided federal ban on a drug that is far less dangerous than alcohol. Decades of arresting people for buying, selling and using marijuana have hurt more than helped society, and minority communities have been disproportionately affected by the harsh criminal penalties of prohibition.

Since Alaska, Oregon and the District of Columbia already allow medical marijuana, taking the next step makes good sense. There are some differences in their proposed initiatives, but they are all worthy of passage.

ALASKA Ballot Measure 2 would make the use and purchase of marijuana legal for those 21 and older, create a marijuana control board and tax the drug at $50 per ounce wholesale. It is already legal for Alaskans to possess small amounts of marijuana in their homes, and surveys indicate that 18 percent of Alaskans smoke marijuana. Ballot Measure 2 would mean that Alaskans could buy it from a store instead of resorting to the black market.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.